Correction to: European Radiology (2018) 28:3840–3847

https://doi.org/10.1007/s00330-018-5323-4

The original version of this article, published on 19 March 2018, unfortunately contained a mistake. In the section “MR examination,” the contrast medium Gadoterate meglumine was incorrectly named Gadodiamide. The correct wording is “Gadoterate meglumine 0.1 mmol/kg (Dotarem; Guerbet, Aulnay-sous-Bois, France) was injected as a bolus intravenously in all patients.”